European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - busulfan - hematopoietic stem cell transplantation - alkyl sulfonates - busulfan fresenius kabi followed by cyclophosphamide (bucy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (hpct) in adult patients when the combination is considered the best available option.busulfan fresenius kabi followed by cyclophosphamide (bucy4) or melphalan (bumel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - pemetrexed - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed fresenius kabi in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed fresenius kabi in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.pemetrexed fresenius kabi is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed fresenius kabi is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - bortezomib - multiple myeloma - antineoplastic agents - bortezomib as monotherapy or in combination with pegylated liposomal doxorubicin or dexamethasone is indicated for the treatment of adult patients with progressive multiple myeloma who have received at least 1 prior therapy and who have already undergone or are unsuitable for haematopoietic stem cell transplantation.bortezomib in combination with melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib in combination with dexamethasone, or with dexamethasone and thalidomide, is indicated for the induction treatment of adult patients with previously untreated multiple myeloma who are eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - soya bean oil, refined ph. eur.; medium chain triglycerides; refined olive oil; fish oil, rich in omega-3 acids; isoleucine; leucine ; methionine; lysine acetate; phenylalanine; threonine; tryptophan; valine; arginine ; histidine; alanine; glycine; proline; serine; tyrosine; taurine; calcium chloride dihydrate; sodium glycerophophate hydrate; magnesium sulphate heptahydrate ; potassium chloride; sodium acetate trihydrate ; zinc sulphate heptahydrate; glucose monohydrate - emulsion for infusion - solutions for parenteral nutrition; combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - l-alanine; l-arginine; glycine; l-histidine; l-isoleucine; l-leucine; l-lysine acetate; l-methionine; l-phenylalanine; l-proline; l-serine; taurine; l-threonine; l-tryptophan; l-tyrosine; l-valine; glucose monohydrate; soya bean oil, refined; triglycerides, medium chain; olive oil, refined; fish oil, rich in omega-3 acids - emulsion for infusion - 0 gram(s) - solutions for parenteral nutrition; combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - alanine; arginine ; glycine; histidine; isoleucine; leucine ; lysine acetate; methionine; phenylalanine; proline; serine; taurine; tryptophan; tyrosine; valine; glucose monohydrate; soya bean oil, refined; triglycerides medium-chain ; olive oil, refined; fish oil, rich in omega-3 acids - emulsion for infusion - solutions for parenteral nutrition; combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - alanine; arginine ; glycine; histidine; isoleucine; leucine ; lysine acetate; methionine; phenylalanine; proline; serine; taurine; tryptophan; tyrosine; valine; calcium chloride dihydrate; sodium glycerophophate hydrate; magnesium sulfate heptahydrate; potassium chloride; sodium acetate trihydrate ; zinc sulphate heptahydrate; glucose monohydrate; soya bean oil, refined; triglycerides medium-chain ; olive oil, refined; fish oil, rich in omega-3 acids - emulsion for infusion - solutions for parenteral nutrition; combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - l-alanine; l-arginine; glycine; l-histidine; l-isoleucine; l-leucine; l-lysine; l-methionine; l-phenylalanine; l-proline; l-serine; taurine; l-threonine; l-tryptophan; l-tyrosine; l-valine; calcium chloride; sodium glycerophophate hydrate; magnesium sulphate heptahydrate; potassium chloride; sodium acetate trihydrate; zinc sulphate heptahydrate; glucose monohydrate; soya bean oil, refined; triglycerides, medium chain; olive oil, refined; fish oil, rich in omega-3 acids - emulsion for infusion - 0 gram(s) - solutions for parenteral nutrition; combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - alanine; arginine ; glycine; histidine; isoleucine; leucine ; lysine acetate; methionine; phenylalanine; proline; serine; taurine; threonine; tryptophan; tyrosine; valine; calcium chloride dihydrate; sodium glycerophophate hydrate; magnesium sulphate heptahydrate ; potassium chloride; sodium acetate trihydrate ; zinc sulphate heptahydrate; glucose monohydrate; soya bean oil, refined; triglycerides, medium chain; olive oil, refined; fish oil, rich in omega-3 acids - emulsion for infusion - solutions for parenteral nutrition; combinations